US2018369232A1PendingUtilityA1
Composite Nanoparticles And Uses Thereof
Assignee: LOS GATOS PHARMACEUTICALS INCPriority: Mar 8, 2016Filed: Jul 3, 2018Published: Dec 27, 2018
Est. expiryMar 8, 2036(~9.6 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 43/00A61K 9/5146A61K 47/6937A61K 47/593A61K 31/4745A61K 9/5138A61K 9/14A61K 47/482
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are composite nanoparticles, methods of making composite nanoparticles and methods of using composite nanoparticles to treat or ameliorate various diseases, such as, for example, cancer.
Claims
exact text as granted — not AI-modified1 . A method for forming composite nanoparticles comprising:
making subunit nanoparticles of diameter between about 10 nm and about 20 nm which include an active ingredient; and assembling the subunit nanoparticles into composite nanoparticles of diameter between about 60 nm and about 400 nm.
2 . The method of claim 1 , wherein the active ingredient is hydrophobic.
3 . The method of claim 1 , wherein the subunit nanoparticles are made by a method comprising:
dissolving the drug in aqueous solution; adding the aqueous solution to an agitated organic polymer solution to form a water-in-oil emulsion; adding the solution to an excess of water including an emulsifier with agitation to form water-in-oil-in-water emulsion; removing the organic solvent.
4 . The method of claim 1 , wherein the subunit nanoparticles are made by a method comprising:
dissolving the drug in volatile water-miscible solvent to form a solution; adding the solution to an agitated aqueous solution of carrier polymer to form an oil-in-water emulsion; and diluting the oil-in-water emulsion with water; and filtering the solution to collect the nanoparticles.
5 . The method of claim 1 , wherein the subunit nanoparticles are made by a method comprising:
dissolving the drug in a water immiscible volatile organic solvent which includes a carrier polymer to form a solution; adding the solution to an excess of water which includes an emulsifier; and removing the solvent.
6 . The method of claim 1 , wherein the subunit nanoparticles are made by a method comprising:
grafting the drug to a water soluble polymer; and aggregating the modified polymer.
7 . The method of claim 1 , wherein the composite nanoparticles are made by a method comprising:
dispersing the subunit nanoparticles in water; adding the dispersed nanoparticles to an agitated water immiscible organic solvent which includes a carrier polymer to form a water in oil solution; adding the water in oil solution to an excess of water which includes an emulsifier; and removing the solvent.
8 . The method of claim 1 , wherein the composite nanoparticles are made by a method comprising:
dissolving the subunit nanoparticles in a water immiscible volatile organic solvent which includes a carrier polymer to form a solution; adding the solution to an excess of water which includes an emulsifier; and removing the solvent.
9 . The method of claim 1 , wherein the composite nanoparticles are crosslinked.
10 . The method of claim 1 , wherein the composite nanoparticles are made by a method comprising crosslinking subunit nanoparticles.
11 . The method of claim 1 , wherein the composite nanoparticle decomposes in tumor tissue.
12 . The method of claim 1 , wherein the composite nanoparticle decomposes below about pH 6.4.
13 . The method of claim 1 , wherein the composite nanoparticle disintegrates into subunit particles at the pH of the interstitial space of the tumor tissue, wherein the pH of the cancer interstitial space is between 5.6 and 6.4.Join the waitlist — get patent alerts
Track US2018369232A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.